Fever, a common symptom in clinical practice, often signals underlying infection or inflammation. Its management, however, can be complex due to varying etiologies and patient responses. This article aims to provide a comprehensive guide for managing fever in clinical practice.
Understanding the physiological mechanisms of fever is crucial. Fever results from an upward adjustment of the body's thermostat in the hypothalamus, often due to pyrogens. These may be exogenous, like bacterial toxins, or endogenous, such as cytokines. Understanding these mechanisms can aid in determining the cause of fever and guide treatment strategies.
Assessment of fever involves a thorough history, physical examination, and targeted investigations. Key aspects include duration, pattern, associated symptoms, and potential exposure to infectious agents. Depending on the clinical scenario, laboratory investigations may range from basic tests such as complete blood count and cultures, to more specific tests like serology or imaging.
Treatment of fever should be etiology-specific and patient-centered. Antipyretics, such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs), are commonly used. However, their use should be judicious, considering potential side effects. In fevers due to infection, appropriate antibiotics or antivirals should be employed. In non-infectious fevers, the underlying cause should be addressed.
Regular monitoring of the patient's temperature, response to treatment, and potential complications is essential. Follow-up is crucial, especially in cases where the fever is persistent or recurrent. This helps ensure that the chosen treatment strategy is effective and allows for adjustments as necessary.
Managing fever in clinical practice requires a comprehensive understanding of its mechanisms, thorough assessment, targeted treatment, and diligent follow-up. By adopting a systematic and patient-centered approach, clinicians can effectively manage fever, alleviating patient discomfort and potentially identifying and addressing serious underlying conditions.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation